Jaw Angle Resection — Cost, Top Hospitals & Success Rates | MyMedicPlus

Jaw angle resection — also termed mandibular angle reduction, mandibular contouring, or gonial angle ostectomy — is a craniofacial surgical procedure that removes or reshapes the projecting posterior-inferior corner of the lower jawbone (the mandibular angle or gonion) to narrow the lower face and create a softer, more tapered facial contour. The procedure is one of the most frequently performed facial skeletal contouring surgeries in East Asia, where a broad or square jaw is often considered aesthetically undesirable, and a slim, oval or pointed 'v-line' or 'egg-face' contour is the predominant aesthetic ideal.

The mandibular angle is the junction between the body and the ramus of the mandible. Its prominence is determined by the underlying bone morphology, the thickness of the overlying masseter muscle, and the subcutaneous soft tissue. In individuals with a broad lower facial width, the mandibular angle is typically positioned more laterally and inferiorly, creating what is described as a 'square' or 'rectangular' lower face. Jaw angle resection addresses the skeletal component directly — reducing the bony angle to diminish lower facial width — while masseter muscle botulinum toxin injections or surgical masseter muscle reduction may be used to address the soft tissue component in the same or staged session.

The procedure is performed entirely through intraoral incisions, leaving no external visible scars. It is a technically demanding operation due to the proximity of important anatomical structures, particularly the inferior alveolar nerve (IAN) and facial vessels, and should be performed by an experienced oral and maxillofacial or craniofacial surgeon. Preoperative three-dimensional CT scanning and computer-aided surgical planning (virtual surgical planning, VSP) are now considered standard of care at reputable centres, enabling precise preoperative simulation and intraoperative guidance.

Jaw angle resection is primarily an aesthetic procedure sought by individuals who are unhappy with the width or squareness of their lower face. The majority of patients seeking this procedure are women in their twenties and thirties from East Asian backgrounds (Korean, Chinese, Japanese, Taiwanese, Vietnamese) for whom a broad mandibular angle creates a lower face that appears disproportionately wide relative to the upper face. The procedure is also sought by men wishing to soften a hyper-masculine jawline.

From a morphological standpoint, candidates typically demonstrate one or more of the following: a mandibular angle that is outwardly flared (gonial eversion), a low gonial point (the angle is positioned inferiorly as well as laterally), a reduced gonial angle measurement (the angle between the posterior ramus and mandibular body is less than approximately 120 degrees, creating a sharp rather than gentle curve), or significant masseter muscle hypertrophy co-existing with bony prominence. The lower facial width-to-height ratio and the bigonial width (distance between the two mandibular angles) are key preoperative measurements.

In addition to purely cosmetic indications, some patients with significant mandibular prognathism (underbite) may undergo combined orthognathic surgery including mandibular setback (sagittal split osteotomy) and simultaneous mandibular angle reduction to correct occlusion and improve aesthetics in one operation. Patients with facial asymmetry due to unequal mandibular angle prominence may also benefit from unilateral or differential bilateral angle reduction. The procedure is not indicated for patients whose broad lower face is primarily due to masseter hypertrophy alone (for whom BTX is preferable) or parotid gland enlargement (which should be assessed separately).

Ideal candidates for jaw angle resection are physically healthy adults (typically over 18 years, preferably with completed skeletal maturity) with documented bony mandibular angle prominence contributing to an overly wide or square lower face. A thorough medical history screens for bleeding disorders, bisphosphonate use (which markedly increases the risk of osteonecrosis), autoimmune conditions, prior mandibular fractures, or significant dental malocclusion that might itself require orthognathic correction.

Preoperative imaging is essential. A panoramic X-ray (orthopantomogram/OPG) provides an initial two-dimensional view of the mandible and establishes the course of the inferior alveolar canal. High-resolution three-dimensional CT scanning of the facial skeleton is mandatory at specialist centres — it accurately defines the exact position of the inferior alveolar nerve canal, the degree of gonial angle prominence, cortical bone thickness, and the presence of any anatomical variants. Virtual surgical planning (VSP) software allows the surgeon and patient to simulate the planned resection and predict the soft tissue outcome before a single incision is made.

Dental occlusion must be formally assessed; patients with a significant malocclusion (class III skeletal prognathism or open bite) should be evaluated by an orthodontist and may require combined orthognathic surgery before or concurrent with angle reduction. Patients taking antiplatelet agents or anticoagulants require appropriate perioperative management. Smoking significantly impairs bone healing and wound healing; cessation for at least 4–6 weeks preoperatively is strongly recommended. Psychological evaluation is advisable in patients with body dysmorphic concerns or unrealistic expectations — careful counselling about achievable outcomes, the prolonged swelling phase, and the possibility of asymmetry is mandatory before proceeding.

Three principal surgical techniques exist for mandibular angle reduction, and the choice depends on the specific anatomy, the degree of correction required, and surgeon expertise:

1. Outer cortex (lateral cortex) resection: Only the outer (lateral) cortical plate of the mandibular angle is removed, preserving the inner cortex and the full structural continuity of the mandible. This technique is effective for reducing lateral flaring of the angle and reduces the risk of inferior alveolar nerve injury because the canal — which runs in the medullary bone — is not approached. It produces a moderate reduction in bigonial width and is often preferred for patients with milder degrees of flaring or those in whom nerve safety is the primary concern.

2. Total angle resection (full-thickness ostectomy): The entire mandibular angle — outer cortex, medullary bone, and inner cortex — is resected along a planned osteotomy line, removing the prominent inferior and posterior projections of the angle. This approach produces the greatest reduction in lower facial width and the most dramatic aesthetic improvement in patients with marked angle prominence. The osteotomy line is planned precisely using virtual surgical planning to ensure the inferior alveolar nerve canal is avoided. A curved or oblique osteotomy creates a smoother contour than a straight cut.

3. Curved or long-curved osteotomy: Rather than removing only the angle itself, a curved osteotomy line is drawn from the angle area extending anteriorly along the mandibular body and superiorly along the ramus. This removes a curved strip of bone producing a smooth, continuous reduction from the gonion along the entire inferior border of the mandible, avoiding the abrupt step deformity that can occur with a localised angle resection. This technique is widely favoured in Korea for producing the smoothest v-line contour and is frequently combined with genioplasty (chin reduction or repositioning) to complete the lower facial transformation.

All techniques are performed entirely via intraoral incisions made through the mucosa overlying the lower third molar region. A subperiosteal dissection exposes the mandibular angle; piezosurgery (ultrasonic bone cutting) or a reciprocating saw is used to perform the osteotomy. The resected bone fragment is removed, the edges are smoothed with a burr, and the wound is closed in layers with resorbable sutures. Intraoperative imaging (C-arm fluoroscopy or cone-beam CT) allows real-time verification that the planned resection has been achieved.

When performed by an experienced craniofacial surgeon with meticulous planning, jaw angle resection produces a reliable, permanent reduction in lower facial width that cannot be achieved by any non-surgical means. The key aesthetic benefits include: a narrower and more tapered lower face with reduced bigonial width, a softer and more oval facial outline when viewed from the front, elimination of the square or rectangular lower face appearance, and — when combined with genioplasty — a harmonious v-line contour from the zygomatic arches to the chin tip.

Published clinical series report patient satisfaction rates exceeding 85–90% when preoperative planning is thorough and patient expectations are realistic. Three-dimensional cephalometric studies demonstrate measurable reductions in bigonial width of 8–18 mm and total mandibular width reduction of 10–20 mm depending on the technique used, with the long-curved osteotomy producing the greatest reduction. Because bone is removed rather than re-positioned, the result is permanent — bony regrowth at the osteotomy site is minimal, though soft tissue ptosis with age will affect the long-term appearance.

Combination with other procedures substantially enhances outcomes. Concurrent genioplasty (chin narrowing by midline wedge ostectomy or T-osteotomy, or chin advancement for a recessed chin) creates the tapering v-line that neither procedure alone achieves. Botulinum toxin injections to the masseter muscle 2–4 weeks after bone healing address the overlying soft tissue component, producing further reduction in lower facial width and preventing masseter hypertrophy from visually masking the skeletal result. The absence of external scars is a major advantage over open facial skeletal surgery, and patients can expect to resume normal social activities within 2–4 weeks once major swelling subsides, though complete resolution of subtle swelling takes 3–6 months.

Jaw angle resection, as a procedure involving bone resection adjacent to critical anatomical structures, carries specific risks that patients must understand before consenting. These range from minor and transient to serious and potentially permanent:

Inferior alveolar nerve (IAN) injury is the most significant nerve-related risk. The IAN runs through the mandibular canal within the body and ramus of the mandible, supplying sensation to the lower lip, chin, and ipsilateral lower teeth. Inadvertent damage during osteotomy may cause temporary paraesthesia (numbness or tingling of the lower lip and chin) in up to 20–40% of cases, the majority of which resolve within 3–12 months. Permanent sensory loss is reported in 1–5% of cases in experienced hands; this risk is substantially reduced by meticulous preoperative CT planning to define the exact canal position.

Facial nerve injury is less common than IAN injury since the marginal mandibular branch of the facial nerve runs superficial to the masseter and well clear of the intraoral dissection plane; however, traction or thermal injury during retraction can cause temporary motor weakness of the lower lip (drooping) in a small percentage of cases.

Masseter muscle injury and trismus occur due to the proximity of the masseter origin to the resection site. Postoperative trismus (difficulty opening the mouth) is common in the first 2–4 weeks and generally resolves with physiotherapy. Persistent trismus is rare.

Asymmetry is a recognised complication even in carefully planned cases, due to pre-existing anatomical asymmetry, differences in bone density, or subtle variations in osteotomy execution. Minor asymmetry detectable only on clinical examination is common; clinically visible asymmetry requiring revision surgery occurs in approximately 3–8% of cases.

Other risks include haematoma, wound dehiscence (intraoral wound breakdown), infection, osteonecrosis of the mandible (particularly with bisphosphonate use), step deformity at the osteotomy edge, and paradoxical widening of the lower face if the masseter muscle herniates inferiorly after the bony support is removed ('masseter ptosis'). General anaesthesia carries its own systemic risks. Revision surgery is required in approximately 5–10% of cases.

Recovery from jaw angle resection follows a predictable course but requires patient commitment over several months. Immediately after surgery, an elastic compression bandage is applied around the face and head and worn continuously for the first 48–72 hours to minimise haematoma formation; thereafter it may be worn at night for 2–4 weeks. Significant facial swelling is expected and peaks at 48–72 hours postoperatively. Most patients describe the appearance as considerably alarming in the first week — reassurance that swelling is temporary is an important part of preoperative counselling.

Diet is restricted to liquids for the first 3–7 days, progressing to soft foods by week 2 and a normal diet by week 4–6 once wound healing is confirmed. Rigorous oral hygiene with antiseptic mouthwash after every meal is essential to prevent intraoral wound infection. Strenuous physical activity should be avoided for 4–6 weeks. Most patients can return to office-based work or university within 10–14 days; patient-facing roles where appearance is important may require 3–4 weeks of social downtime.

Follow-up appointments are typically scheduled at 1 week (wound check and suture inspection), 4 weeks (dietary progression review, early outcome assessment), 3 months (near-complete swelling resolution, nerve function assessment), and 6–12 months (final outcome review, decision about adjunctive BTX if planned). Panoramic radiography or CT at 3–6 months confirms bone remodelling and healing at the osteotomy site. If IAN paraesthesia is present at 3 months, nerve conduction studies may be performed and vitamin B12 supplementation is often advised. Masseter botulinum toxin injections are scheduled once bone healing is confirmed, typically at 3–4 months postoperatively.

Jaw angle resection is one of the most popular procedures in medical tourism, particularly in South Korea, which is globally recognised as the leading destination for facial skeletal contouring surgery. The concentration of highly experienced craniofacial surgeons, advanced 3D planning technology, and competitive pricing has made Seoul the de facto world centre for v-line surgery. Taiwan, China, and Thailand are also established destinations.

Procedure costs (surgeon fee, anaesthesia, hospital/clinic, and facility charges combined) range approximately as follows: South Korea (Seoul) USD 6,000–15,000; Taiwan USD 5,000–12,000; Thailand (Bangkok) USD 4,000–10,000; China USD 3,000–8,000. These figures are significantly lower than comparable procedures in the United States (USD 20,000–40,000) or Western Europe (GBP 15,000–30,000). Medical tourism packages may include airport transfers, accommodation, and translation services; the additional travel, accommodation, and aftercare logistics cost USD 1,500–4,000 depending on origin country and duration of stay.

Additional cost factors include whether genioplasty or other concurrent procedures are performed (adding USD 2,000–6,000 per additional procedure), the need for 3D CT scanning and VSP (USD 300–1,000), and postoperative adjunctive botulinum toxin injections (USD 200–600 per session). Revision surgery, if required, typically costs 40–70% of the primary procedure cost. Patients travelling abroad for jaw angle resection must budget for a minimum stay of 10–14 days for initial recovery and the first wound check before flying; early air travel may worsen swelling and increase infection risk. Comprehensive travel insurance covering surgical complications and medical evacuation is strongly recommended.

For patients seeking lower facial width reduction who are not ready for surgery or who have predominantly soft-tissue (rather than skeletal) causes of a broad jaw, several non-surgical and minimally invasive alternatives exist:

Botulinum toxin (BTX) masseter reduction is the most widely used non-surgical approach. Injections of 20–40 units of botulinum toxin type A (onabotulinumtoxinA or abobotulinumtoxinA) per side into the masseter muscle produce selective muscle weakness, leading to progressive muscle atrophy over 3–6 months. This is highly effective when masseter hypertrophy is the primary cause of lower facial width. The effect lasts approximately 4–6 months with initial treatments, but with repeated injections over 2–3 years, persistent muscle atrophy often reduces the required maintenance frequency. BTX masseter reduction is not effective for skeletal (bony) prominence and produces more modest width reduction than surgical resection — typically 3–8 mm versus 10–20 mm for surgery.

Facial contouring with injectable fillers can create an illusion of a narrower lower face by augmenting the mid-face (cheekbones, temples) to balance proportions, without actually reducing the jaw. Hyaluronic acid or calcium hydroxyapatite fillers placed at the zygoma and temple achieve this 'upper face widening' effect and are fully reversible. This approach is suitable for patients who want subtle improvement without any downtime.

High-intensity focused ultrasound (HIFU) and radiofrequency (RF) devices are marketed for facial slimming but have limited evidence for bony reduction; they may modestly improve overlying skin laxity and subcutaneous fat.

For patients requiring occlusal correction in addition to jaw narrowing, combined orthognathic surgery (mandibular setback sagittal split osteotomy + angle reduction) addresses both functional and aesthetic goals simultaneously. This involves longer recovery but avoids the need for two separate procedures. All non-surgical approaches should be discussed with the treating surgeon, as some (particularly fillers) may interfere with postoperative assessment of surgical outcomes if surgery is planned subsequently.